WHO cautious on Covid-19 plasma as US issues emergency authorization
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WHO cautious on Covid-19 plasma as US issues emergency authorization

Coronavirus chronicle

Reuters
24 August, 2020, 05:55 pm
Last modified: 24 August, 2020, 05:59 pm

Related News

  • Kamala Harris calls for assault weapons ban
  • US extends tariff exclusions on Chinese Covid-19 medical products
  • Mass shooting in US: Here's where the guns came from
  • Trump urges end to gun-free school zones
  • US Army signs $687 million deal to restock Stingers after Ukraine shipments

WHO cautious on Covid-19 plasma as US issues emergency authorization

"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said

Reuters
24 August, 2020, 05:55 pm
Last modified: 24 August, 2020, 05:59 pm
A logo is pictured at the World Health Organization (WHO) building in Geneva, Switzerland, February 2, 2020. Picture taken February 2, 2020. REUTERS/Denis Balibouse
A logo is pictured at the World Health Organization (WHO) building in Geneva, Switzerland, February 2, 2020. Picture taken February 2, 2020. REUTERS/Denis Balibouse

The World Health Organization on Monday was cautious about endorsing the use of recovered Covid-19 patients' plasma to treat people who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.

"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said.

"Only a few of them have actually reported interim results...and at the moment, it's still very low-quality evidence," she told a news conference.

World Health Organization (WHO) / Covid-19 Plasma Therapy / USA

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters
    Interbank exchange rate for dollar set at Tk89
  • A Regio regional passenger train operated by Deutsche Bahn AG travels on a bridge in Berlin. Photographer: Krisztian Bocsi/Bloomberg
    Why Germany is offering a summer of cheap trains
  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs

MOST VIEWED

  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Shanghai to lift 'unreasonable' curbs on firms, Beijing eases restrictions
  • Photo: Collected
    US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    'Tomorrow will be better': Shanghai inches towards Covid re-opening
  • North Korea says new fever cases under 100,000 as virus fight heats up
    North Korea says new fever cases under 100,000 as virus fight heats up
  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings

Related News

  • Kamala Harris calls for assault weapons ban
  • US extends tariff exclusions on Chinese Covid-19 medical products
  • Mass shooting in US: Here's where the guns came from
  • Trump urges end to gun-free school zones
  • US Army signs $687 million deal to restock Stingers after Ukraine shipments

Features

Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters

Venice has a 400-year-old Covid monetary lesson

2h | Panorama
Aiman R Khan. Illustration: TBS

Why ‘marry your rapist’ court orders are not always what they seem

5h | Thoughts
Photo: Collected

Top 3 The Ordinary products that give extraordinary results

7h | Mode
Photo: Courtesy

KVN Beauty: Channel your inner Bangalee baddie

7h | Mode

More Videos from TBS

Paper industry worth thousands of crores in Bogura

Paper industry worth thousands of crores in Bogura

1h | Videos
Photo: TBS

Tips to help you become a successful lawyer

8h | Videos
Photo: TBS

Harassment over 'indecent clothing': Women gather at Narsingdi railway station to protest, show solidarity

8h | Videos
People bid adieu to Abdul Gaffar Chowdhury

People bid adieu to Abdul Gaffar Chowdhury

8h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab